Dow Up0.25% Nasdaq Up0.65%

Pacific Biosciences of California, Inc. (PACB)

9.16 Up 0.30(3.39%) May 27, 4:00PM EDT
|After Hours : 9.16 0.00 (0.00%) May 27, 4:24PM EDT
ProfileGet Profile for:
Pacific Biosciences of California, Inc.
1380 Willow Road
Menlo Park, CA 94025
United States - Map
Phone: 650-521-8000

Index Membership:N/A
Full Time Employees:394

Business Summary 

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company’s single molecule real-time (SMRT) sequencing technology enables single molecule real-time detection of biological processes. It offers PacBio RS II and Sequel Systems that conducts, monitors, and analyzes biochemical sequencing reactions. The company also provides consumable products, including sealed and packaged SMRT cells, as well as various reagent kits, such as template preparation, binding, and sequencing kits to run the PacBio RS II or Sequel System. Its customers include research institutions; commercial laboratories; genome centers; clinical, government, and academic institutions; genomics service providers; pharmaceutical companies; and agricultural companies. The company markets its products through a direct sales force in North America and Europe, as well as primarily through distributors in Asia. The company was formerly known as Nanofluidics, Inc. Pacific Biosciences of California, Inc. was founded in 2000 and is headquartered in Menlo Park, California.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Pacific Biosciences of California, Inc.

Corporate Governance 
Pacific Biosciences of California, Inc.’s ISS Governance QuickScore as of May 1, 2016 is 8. The pillar scores are Audit: 1; Board: 7; Shareholder Rights: 7; Compensation: 9.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
Dr. Michael W. Hunkapiller Ph.D., 67
Exec. Chairman, Chief Exec. Officer and Pres
Ms. Susan K. Barnes , 62
Chief Financial Officer, Principal Accounting Officer and Exec. VP
Mr. James Michael Phillips , 65
Sr. VP of R&D
Mr. Kevin P. Corcoran , 57
Sr. VP of Market Devel.
Dr. Stephen Turner Ph.D., 48
Co-Founder, Chief Technology Officer and VP
Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders